Drawing based on the description in the official product monograph. No photo yet.
“30 mg: Hard gelatin capsules with black opaque body and pink opaque cap. Imprinted "APO L30" in white ink”
APO L30 pill
Pill with imprint APO L30 is black & pink, capsule and has been identified as Lansoprazole 30 mg. It is used for acid reflux (GERD), ulcers and stomach ulcers. It is supplied by Apotex Inc.
Sold in Canada
Lansoprazole 30 mg
- Brand
- Apo-Lansoprazole
- Imprint
- APO L30
- Strength
- 30 mg
- Used for
- Acid reflux (GERD), ulcers and stomach ulcers
- Color
- Black, Pink
- Shape
- Capsule / oblong
- Form
- Capsule (delayed-release)
- Manufacturer
- Apotex Inc
- Drug class
- Acid reducer (proton pump inhibitor)
- Sold in
- Canada
- DIN
- 02293838
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Lansoprazole used for?
Lansoprazole is used for acid reflux (GERD), ulcers, stomach ulcers and H. pylori infection.
- Medicine type
- Acid reducer (proton pump inhibitor)
Official uses from the US prescribing label
Treatment of Active Duodenal Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer.
Eradication of H. pylori to Reduce the Risk of Duodenal Ulcer Recurrence
Triple Therapy: Lansoprazole delayed-release orally disintegrating tablets /amoxicillin/clarithromycin
Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Please refer to the full prescribing information for amoxicillin and clarithromycin.
Dual Therapy: Lansoprazole delayed-release orally disintegrating tablets/amoxicillin
Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin as dual therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected (see the clarithromycin prescribing information, Microbiology section). Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Please refer to the full prescribing information for amoxicillin.
Maintenance of Healed Duodenal Ulcers
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults to maintain healing of duodenal ulcers. Controlled studies do not extend beyond 12 months.
Treatment of Active Benign Gastric Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (up to eight weeks) for healing and symptom relief of active benign gastric ulcer.
Healing of NSAID-Associated Gastric Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for the treatment of NSAID-associated gastric ulcer in patients who continue NSAID use. Controlled studies did not extend beyond eight weeks.
Risk Reduction of NSAID-Associated Gastric Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for reducing the risk of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID. Controlled studies did not extend beyond 12 weeks.
Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD)
Lansoprazole delayed-release orally disintegrating tablets are indicated for short-term treatment in adults and pediatric patients 12 to 17 years of age (up to eight weeks) and pediatric patients one to 11 years of age (up to 12 weeks) for the treatment of heartburn and other symptoms associated with GERD.
Treatment of Erosive Esophagitis (EE)
Lansoprazole delayed-release orally disintegrating tablets are indicated for short-term treatment in adults and pediatric patients 12 to 17 years of age (up to eight weeks) and pediatric patients one to 11 years of age (up to 12 weeks) for healing and symptom relief of all grades of EE. For adults who do not heal with lansoprazole delayed-release orally disintegrating tablets for eight weeks (5 to 10%), it may be helpful to give an additional eight weeks of treatment. If there is a recurrence of erosive esophagitis an additional eight week course of lansoprazole delayed-release orally disintegrating tablets may be considered.
Maintenance of Healing of EE
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults to maintain healing of EE. Controlled studies did not extend beyond 12 months.
Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (ZES)
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows APO L30. The parts can be split between the two sides, so turn the pill over and check both.
- It is black & pink, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Apo-Lansoprazole by Apotex Inc.
In Canada: prescription only.
Ingredients
Active: Lansoprazole
Other pills with imprint APO L30
Same imprint, different listing. Check the color, size and maker against your pill.
- APO L30 Lansoprazole 30 mg Black & pink, capsule Used for acid reflux (GERD) and ulcers
- APO L30 Lisdexamfetamine Dimesylate 30 mg Orange & white, capsule, 14 mm Used for ADHD and binge drinking Schedule II
- APO L30 Lisdexamfetamine Dimesylate 30 mg White, triangle Used for ADHD and binge drinking
- APO L30 Lisdexamfetamine Dimesylate 30 mg Orange & white, capsule Used for ADHD and binge drinking
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
barr 033
Chlordiazepoxide Hydrochloride 10 mg
Black & green, capsule, 14 mm
Used for anxiety and alcohol withdrawal
Schedule IV
- LNP200 NVR Iptacopan Hydrochloride 200 mg Black & yellow, capsule Used for paroxysmal hemoglobinuria
- NIT 100 Nitrofurantoin 100 mg Black, capsule Used for urinary tract infections (UTIs) and escherichia coli infections
- HU 500 Hydroxyurea 500 mg Black & pink, capsule Used for psoriasis and prostate cancer
- HP551 HP551 Trientine Hydrochloride 250 mg Black & red, capsule Used for hepatolenticular degeneration and nervous system heavy metal poisoning
- IDN 50 Indomethacin 50 mg Black & blue, capsule Used for pain and rheumatoid arthritis
Other Lansoprazole pills
-
RDY LAN
Lansoprazole 15 mg
Green & pink, capsule, 16 mm
Used for acid reflux (GERD) and ulcers
-
RDY 399
Lansoprazole 30 mg
Black & pink, capsule, 19 mm
Used for acid reflux (GERD) and ulcers
- TAP PREVACID 15 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- TAP PREVACID 15 Lansoprazole 15 mg Green, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- 15 Lansoprazole 15 mg White, round, 9 mm Used for acid reflux (GERD) and ulcers
- 93 7350 Lansoprazole 15 mg Blue & white, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- W 669 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- RDY 398 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers